VIBERZI Drug Profile: VIBERZI (eluxadoline) drug patents, FDA exclusivity, litigation, drug prices

by DrugPatentWatch

VIBERZI Drug Profile, 2023

This report focuses on VIBERZI and covers the following critical aspects of this drug:

United States patentsDistrict Court patent litigationEuropean supplementary protection certificates (SPCs)Clinical trialsDrug pricesFinished product suppliersRaw active pharmaceutical ingredient (API) sourcesContentsProfile for VIBERZIUS PatentsUS District Court LitigationInternational (exUS) PatentsSupplementary Protection CertificatesClinical...

• Format: Paperback
• Language: English
• ISBN: B0CFCZ5MP6
• ISBN13: 9798857082928
• Release Date: August 2023
• Publisher: Independently Published
• Length: 104 Pages
• Weight: 0.58 lbs.
• Dimensions: 0.2" x 8.5" x 11.0"